Imipramine for the treatment of fibrositis: A therapeutic trial

A. J. Wysenbeek, F. Mor, Y. Lurie, A. Weinberger

Research output: Contribution to journalArticlepeer-review


Twenty fibrositic patients were treated with imipramine 50-75 mg/day. Only two patients responded favourably. Nineteen patients stopped therapy during the initial three-month period; 14 of them due to lack of response, while to of these concomitantly disclosed side effects. The additional five patients stopped therapy mainly due to side effects while only one of them improved with therapy. One patient, only, improved and adhered to therapy for more than three months.

Original languageEnglish
Pages (from-to)752-753
Number of pages2
JournalAnnals of the Rheumatic Diseases
Issue number11
StatePublished - 1985


Dive into the research topics of 'Imipramine for the treatment of fibrositis: A therapeutic trial'. Together they form a unique fingerprint.

Cite this